NCT00000920 - Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 2003

Conditions

HIV InfectionsPregnancy

Interventions

DRUG

Ritonavir

DRUG

Saquinavir

DRUG

Lamivudine

DRUG

Zidovudine

Trial Locations (15)

10032

Columbia Presbyterian Med Ctr, New York

20060

Howard Univ Hosp, Washington D.C.

33136

Univ of Miami / Jackson Memorial Hosp, Miami

33161

Univ of Miami (Pediatric), Miami

48201

Children's Hosp of Michigan, Detroit

60612

Univ of Illinois College of Medicine / Pediatrics, Chicago

70112

Univ Hosp, New Orleans

80262

Univ of Colorado Health Sciences Ctr, Denver

90033

Los Angeles County - USC Med Ctr, Los Angeles

277103499

Duke Univ Med Ctr, Durham

294253312

Med Univ of South Carolina, Charleston

701122699

Tulane Univ / Charity Hosp of New Orleans, New Orleans

981050371

Children's Hospital & Medical Center / Seattle ACTU, Seattle

071032714

Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark

009365067

Univ of Puerto Rico / Univ Children's Hosp AIDS, San Juan

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH